Citation: | GE Si-chen, JIANG Cheng-yi. Effects of miR-34a on proliferation and epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by targeting FOXM1[J]. Chinese Journal of General Practice, 2021, 19(12): 2012-2015,2023. doi: 10.16766/j.cnki.issn.1674-4152.002223 |
[1] |
CHEN Y P, CHAN A T C, LE Q T, et al. Nasopharyngeal carcinoma[J]. Lancet, 2019, 394(10192): 64-80. doi: 10.1016/S0140-6736(19)30956-0
|
[2] |
ZOU Y, YANG R, HUANG M L, et al. NOTCH2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma[J]. J Exp Clin Cancer Res, 2019, 38(1): 456. doi: 10.1186/s13046-019-1463-x
|
[3] |
杨年婷, 刘超, 李果, 等. MiR-324-3p经上皮-间质转化调控鼻咽癌迁移侵袭的实验分析[J]. 中国耳鼻咽喉颅底外科杂志, 2016, 22(2): 95-99. https://www.cnki.com.cn/Article/CJFDTOTAL-ZEBY201602006.htm
|
[4] |
浦立, 蒋学范, 余韵, 等. 鼻咽癌组织中miR-634水平及其对鼻咽癌细胞生长的影响及机制研究[J]. 中华全科医学, 2019, 17(9): 1474-1477. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201909012.htm
|
[5] |
SLABÁKOVÁ E, CULIG Z, REMŠÍK J, et al. Alternative mechanisms of miR-34a regulation in cancer[J]. Cell Death Dis, 2017, 8(10): e3100. doi: 10.1038/cddis.2017.495
|
[6] |
徐建萍, 叶丽君, 喻长法, 等. miR-34a和miR-21在宫颈癌中的表达及其临床意义[J]. 中国卫生检验杂志, 2020, 30(11): 1281-1283. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ202011001.htm
|
[7] |
郝志明, 李华伟, 王立军. miR-34a、CD133在胰腺癌中的表达及临床意义[J]. 现代肿瘤医学, 2020, 28(12): 2094-2099. doi: 10.3969/j.issn.1672-4992.2020.12.022
|
[8] |
WANG L Y, BO X T, ZHENG Q H, et al. Paired box 8 suppresses tumor angiogenesis and metastasis in gastric cancer through repression of FOXM1 via induction of microRNA-612[J]. J Exp Clin Cancer Res, 2018, 37(1): 159. doi: 10.1186/s13046-018-0830-3
|
[9] |
GARTEL A L. FOXM1 in cancer: Interactions and vulnerabilities[J]. Cancer Res, 2017, 77(12): 3135-3139. doi: 10.1158/0008-5472.CAN-16-3566
|
[10] |
李凡玲, 田虎, 周明, 等. FOXM1在鼻咽癌患者中的表达特点及临床意义[J]. 癌症进展, 2018, 16(7): 878-880. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ201807022.htm
|
[11] |
曲宝亮, 穆怀博, 勾建强, 等. lncRNA HCG18/miR-17-5p/HMGA2分子轴调控非小细胞肺癌细胞增殖及迁移[J]. 中国肿瘤生物治疗杂志, 2019, 26(4): 409-416. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLSW201904007.htm
|
[12] |
柳伟, 蒋成义, 江涛, 等. MiR-34a在人鼻咽癌中的表达及临床意义[J]. 河北北方学院学报(自然科学版), 2018, 34(10): 5-8. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJKN201810003.htm
|
[13] |
程忠强, 蒋成义, 韩跃峰, 等. miR-34a对鼻咽癌细胞增殖的负性调控作用[J]. 中国现代药物应用, 2020, 14(10): 234-236. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWYY202010115.htm
|
[14] |
HE Y, JIN J, WANG L, et al. Evaluation of miR-21 and miR-375 as prognostic biomarkers in oesophageal cancer in high-risk areas in China[J]. Clin Exp Metastasis, 2017, 34(1): 73-84. doi: 10.1007/s10585-016-9828-4
|
[15] |
LI L, WU D, YU Q, et al. Prognostic value of FOXM1 in solid tumors: A systematic review and meta-analysis[J]. Oncotarget, 2017, 8(19): 32298-32308. doi: 10.18632/oncotarget.15764
|
[16] |
ZHU X, LU K, CAO L, et al. FoxM1 is upregulated in osteosarcoma and inhibition of FoxM1 decreases osteosarcoma cell proliferation, migration, and invasion[J]. Cancer Manag Res, 2020, 12: 9857-9867. doi: 10.2147/CMAR.S270825
|
[17] |
PASTUSHENKO I, BLANPAIN C. EMT transition states during tumor progression and metastasis[J]. Trends Cell Biol, 2019, 29(3): 212-226. doi: 10.1016/j.tcb.2018.12.001
|
[18] |
DU B, SHIM J S. Targeting Epithelial-Mesenchymal Transition (EMT) to overcome drug resistance in cancer[J]. Molecules, 2016, 21(7): 965. doi: 10.3390/molecules21070965
|
[19] |
GASINSKA A, JASZCZYNSKI J, ADAMCZYK A, et al. Biomarkers of epithelial-mesenchymal transition in localized, surgically treated clear-cell renal cell carcinoma[J]. Folia Histochem Cytobiol, 2018, 56(4): 195-206.
|
[20] |
陈顺金, 吴笑英, 何锦添, 等. Trop2与EMT相关蛋白E-Cadherin在鼻咽癌中的表达及临床意义[J]. 新医学, 2019, 50(9): 708-713. doi: 10.3969/j.issn.0253-9802.2019.09.014
|
[21] |
付祎婷. Vimentin调控Annexin A1和S100A9的表达对鼻咽癌侵袭迁移的影响[D]. 衡阳: 南华大学, 2019.
|
1. | 覃熙媛,朱莹,李伟滔,郑晓玲,梁远秋. 上皮性卵巢癌组织中FoxM1的表达及其临床意义. 癌变·畸变·突变. 2023(04): 273-278 . ![]() |